This research is devoted to the investigation of the general trends in the development of the pharmaceutical industry in the current conditions of economical socialization. The determination of the economic specificity of the modern operation of the pharmaceutical industry is the purpose of the research. It was found that pharmacy is a profitable sphere of investment in spite of the economic crisis. Furthermore, it was found that national pharmaceutical markets of developing countries contributed significantly to the national economies (since the job of locating pharmaceutical manufacturing facilities is being vacated by developed countries), while the markets of developed countries facilitated the prospering of the economies of their countries (since new ways of making manufacturing cheaper provides for comfortable business). In addition, the correlation of data on export and import of pharmaceutical products gives an idea of the leaders of the pharmaceutical market and the peculiarities of their work. The research also found that the manufacturing of generic drugs was a promising branch of pharmacy. The novelty of this research is determined by the necessity of a comprehensive analysis of rapidly changed trends, which can serve as the basis from relevant economic planning.

Adriaenssens, N. (2015). Systemic Antimycotic and Antifungal Use in Eastern Europe. Journal of Antimicrobial Chemotherapy, 5, 54-64.

Bettiol, E. (2015). Challenges and Solutions for Clinical Development of New Antibacterial Agents: Results of a Survey Among Pharmaceutical Industry Professionals. Antimicrobial Agents and Chemotherapy, 59(7), 95-99.

Blanc, L. (2015). The European Pharmaceutical Industry in a Global Economy: What Drives EU Exports of Pharmaceuticals? Bruges European Economic Research Papers, 31, 28-34.

Chen, Y. & Fu, F. Q. (2015). The Behavioral Consequences of Service Quality: An Empirical Study in the Chinese Retail Pharmacy Industry. Health Marketing Quarterly, 32(1), 14-30.

Diestre L., Rajagopalan N. & Dutta S. (2015). Constraints in Acquiring and Utilizing Directors' Experience: An Empirical Study of New‐Market Entry in the Pharmaceutical Industry. Strategic Management Journal, 36(3), 339-359.

Dixit, M. R, & Yadav, S. (2015). Motivations, Capability Handicaps, and Firm Responses in the Early Phase of Internationalization: A Study in the Indian Pharmaceutical Industry. Journal of Global Marketing, 28(1), 1-18.

Dogramatzis, D. (2015). Pharmaceutical Marketing. New York: Taylor & Francis, 403 p.

Dong, J. Q. & Yang, C. H. (2015). Information Technology and Organizational Learning in Knowledge Alliances and Networks: Evidence from US Pharmaceutical Industry. Information & Management, 52(1), 111-122.

Gautam, A. & Pan, X. (2016). The Changing Model of Big Pharma: Impact of Key Trends. Drug Discovery Today, 21(3), 379-384.

Hartung, D. M. (2015). The Cost of Multiple Sclerosis Drugs in the US and the Pharmaceutical Industry Too Big to Fail? Neurology, 84(21), 85-92.

Liu, M. & La Croix, S. (2015). A Cross-country Index of Intellectual Property Rights in Pharmaceutical Inventions. Research Policy, 44(1), 206-216.

Norazmi, M. N. & Lim, L. S. (2015). Halal Pharmaceutical Industry: Opportunities and Challenges. Trends in Pharmacological Sciences, 36(8), 496-497.

O'Brien, S. (2015). Meeting the Societal Need for New Antibiotics: the Challenges for the Pharmaceutical Industry. British Journal of Clinical Pharmacology, 79(2), 168-172.

Ogorodova, L. M. (2016). Model Breakthrough Technologies as a Tool to Support Import Substitution in the Pharmaceutical Industry. International Review of Management and Marketing, 6, 56-67.

Pan, H. Q. (2016). Chinese Manufacturing Industry Development Strategy from the Financial Perspective: Grey Modeling and Analysis of Data from the Listing Corporation China Pharmaceutical Manufacturing Enterprises. Grey Systems: Theory and Application, 6(2), 45-56.

Paolucci, V. (2015). The Role of Collective Bargaining in Addressing Flexibility and Security. Warwick: University of Warwick, 356 p.

Roschangar, F., Sheldon, R. A. & Senanayake, C.H. (2015). Overcoming Barriers to Green Chemistry in the Pharmaceutical Industry–the Green Aspiration Level™ Concept. Green Chemistry, 17(2), 752-768.

Suri, F. K. & Banerji, A. (2016). Super Generics—First Step of Indian Pharmaceutical Industry in the Innovative Space in US Market. Journal of Health Management, 6, 133 -145.

Talassov, G. & Abdrakhmanova, G. (2015). Actual Problems and Prospects of the Pharmaceutical Market. Asian Social Science, 11(19), 264 p.

Whiteman, J., Mc.Veigh, O., & Watters, M. (2016). Hospital Pharmacy and the Pharmaceutical Industry Collaborate to Reduce Waste of Biologic Medicine. Rheumatology, 55(1), 192 p.